Publications by authors named "M Montembault"

Claim this Profile
A
An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial.
Anthony Cahn, J Nicole Hamblin, Jon Robertson, Malcolm Begg, Emily Jarvis, Mickael Montembault

Int J Chron Obstruct Pulmon Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib.
M Begg, R Wilson, J N Hamblin, M Montembault, J Green

J Pharmacol Exp Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma.
Sanjeev Khindri, Anthony Cahn, Malcolm Begg, Mickael Montembault, Claudia Leemereise

J Pharmacol Exp Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy Subjects.
Robert Wilson, Emily Jarvis, Mickael Montembault, J Nicole Hamblin, Edith M Hessel

Clin Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD.
A Cahn, J N Hamblin, M Begg, R Wilson, L Dunsire, M Montembault

Pulm Pharmacol Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis